ask="2.80"
ask_size="100"
average_daily_volume="88380"
bid="2.20"
bid_size="2000"
book_value="1.40"
change="-0.08"
change_from_200_day_moving_average="1.32"
change_from_50_day_moving_average="1.16"
change_from_52_week_high="-5.60"
change_From_52_week_low="0.15"
change_in_percent="-3.43%"
close="2.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="1824000"
high="2.38"
high_52_weeks="7.85"
last_trade_date="2/21/2017"
last_trade_price="2.25"
last_trade_size="576"
last_trade_time="4:00pm"
low="2.10"
low_52_weeks="2.10"
market_capitalization="6.03M"
moving_average_200_day="0.93"
moving_average_50_day="1.09"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.38"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+141.29%"
percent_change_from_50_day_moving_average="+106.20%"
percent_change_from_52_week_high="-71.34%"
percent_change_from_52_week_low="+7.14%"
previous_close="2.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.66"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.12"
stock_exchange="NCM"
symbol="XTLB"
volume="269732"
weeks_range_52="2.10 - 7.85"
